Get complete Patent Opposition Report for Sanofi Pasteur

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Sanofi Pasteur

Explore patent oppositions filed by Sanofi Pasteur against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3583947Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZERJul 11, 2024
EP3246044Stable Formulations Of Neisseria Meningitidis Rlp2086 AntigensWYETHSep 29, 2021
EP3096785Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZERJun 8, 2021
EP2976101Method Of TreatmentGLAXOSMITHKLINE BIOLOGICALSMay 18, 2021
EP2411048Adjuvanting Meningococcal Factor H Binding ProteinGLAXOSMITHKLINE BIOLOGICALSFeb 5, 2021
EP2869843Complexes Of Cytomegalovirus ProteinsGLAXOSMITHKLINE BIOLOGICALSMay 7, 2020
EP2676679Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETHOct 2, 2019
EP3017827Pneumococcal Polysaccharide Conjugate VaccineGLAXOSMITHKLINE BIOLOGICALSAug 6, 2019
EP2918684Rapid Sterility MicroassayNOVARTISOct 10, 2018
EP3106176Aluminium Compounds For Use In Therapeutics And VaccinesVALNEVA AUSTRIAJul 10, 2018

Explore Sanofi Pasteur's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3007724Jul 5, 2023Compositions And Methods Of Immunizing Against C. Difficile1
EP3679915Jun 1, 2022Flavivirus Vaccines2
EP2851087Apr 19, 2017Stabilization Of Vaccines By Lyophilization1